Inhibition of allergic reactions by cromoglycate and by AH 7079 in patients with allergic airway disease.
D000281:Administration, Intranasal; D000328:Adult; D000336:Aerosols; D000485:Allergens; D001249:Asthma / Q000276:immunology / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D004205:Cromolyn Sodium / Q000627:therapeutic use*; D003888:Desensitization, Immunologic; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007108:Immune Tolerance; D008297:Male; D008738:Methyl Ethers / Q000008:administration & dosage / Q000627:therapeutic use; D008875:Middle Aged; D011058:Pollen; D012129:Respiratory Function Tests; D013777:Tetrazoles / Q000008:administration & dosage / Q000627:therapeutic use; D014966:Xanthenes / Q000008:administration & dosage / Q000627:therapeutic use*; D044004:Xanthones
D000336:Aerosols; D000485:Allergens; D008738:Methyl Ethers; D013777:Tetrazoles; D014966:Xanthenes; D044004:Xanthones; C006210:AH 7079; D004205:Cromolyn Sodium